Abstract
Get full access to this article
View all access options for this article.
References
1.
.
Kaklamani
VG
,
Vaiopoulos
G
,
Kaklamanis
PG
. Behcet's disease . Semin Arthritis Rheum
1998 ; 27 : 197 –217 .
2.
.
Turan
B
,
Gallati
H
,
Erdi
H
,
Gurler
A
,
Mchel
BA
,
Villiger
PM
. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease; soluble TNFR-75 as a biological marker of disease activity . J Rheumatol
1997 ; 24 : 128 –32 .
3.
.
Sfikakis
PP
,
Theodossiadis
PG
,
Katsiari
CG
,
Kaklamanis
P
,
Marko-michelakis
NN
. Effect of infliximab on sight-threatening panuveitis in Behcet's disease . Lancet
2001 ; 358 : 295 –6 .
4.
.
Joseph
A
,
Raj
D
,
Dua
HS
,
Powell
PT
,
Lanyon
PC
,
Powell
RJ
. Infliximab in the treatment of refractory posterior uveitis . Ophthalmology
2003 ; 110 : 1449 –53 .
5.
.
Muñoz-Fernandez
S
,
Hidalgo
V
,
Fernandez-Melon
J
,
Schlincker
A
,
Martin-Mola
E
. Effect of infliximab on threatening panuveitis in Behcet's disease (letter) . Lancet
2001 ; 358 : 1644 .